US Patent 7465715 Method for treatment of multiple sclerosis
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Lea Madi0
Pnina Fishman0
Sara Bar Yehuda0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
Individuals suffering from multiple sclerosis may be treated by administration of an A3 adenosine receptor agonist (A3RAg), such as APNEA, AB-MECA, IB-MECA or Cl-IB-MECA. The A3RAg is preferably administered orally with a pharmaceutically acceptable carrier.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07465715 Method for treatment of multiple sclerosis US Patent 7465715 Method for treatment of multiple sclerosis
Infobox
Patent Number
074657150
Patent Number
74657150
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
074657150
Date of Patent
December 16, 2008
0Patent Application Number
105211930
Date Filed
December 23, 2004
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07465715 Method for treatment of multiple sclerosis
Infobox
Is a
Patent jurisdiction
Patent number
07465715
Date of patent
December 16, 2008
Patent application number
10521193
Date Filed
December 23, 2004
Patent primary examiner
Find more entities like US Patent 7465715 Method for treatment of multiple sclerosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
